Lucid Diligence Brief: Human Health A$8.5m raise in women’s health
Lucid Diligence Brief: Human Health A$8.5m raise in women’s health Professional…
Lucid Diligence Brief: Novo Nordisk proposal to acquire Metsera
Lucid Diligence Brief: Novo Nordisk proposal to acquire Metsera Professional…
Lucid Diligence Brief: GSK licenses Empirico's siRNA in COPD
Lucid Diligence Brief: GSK licenses Empirico's siRNA in COPD Professional…
Lucid Diligence Brief: Lilly to acquire Adverum Biotechnologies
Lucid Diligence Brief: Lilly to acquire Adverum Biotechnologies Professional…
Lucid Diligence Brief: Takeda and Innovent global oncology partnership
Lucid Diligence Brief: Takeda and Innovent global oncology partnership…
Lucid Diligence Brief: Hologic acquisition by Blackstone and TPG
Lucid Diligence Brief: Hologic acquisition by Blackstone and TPG Professional…
Lucid Diligence Brief: HealthVerity and Claritas Rx partnership
Lucid Diligence Brief: HealthVerity and Claritas Rx partnership Professional…
Lucid Diligence Brief: Samsung and GRAIL LOI, Galleri MCED rollout in Asia
Lucid Diligence Brief: Samsung and GRAIL LOI, Galleri MCED rollout in Asia…
Lucid Diligence Brief: Tubulis €308m Series C, NaPi2b ADC TUB-040
Lucid Diligence Brief: Tubulis €308m Series C, NaPi2b ADC TUB-040 Professional…
Lucid Diligence Brief: Kailera Therapeutics $600m Series B
Lucid Diligence Brief: Kailera Therapeutics $600m Series B Professional…
Lucid Diligence Brief: Shuttle Pharma x Molecule.ai LOI
Lucid Diligence Brief: Shuttle Pharma x Molecule.ai LOI Professional audiences…
Lucid Diligence Brief: Ascenta Capital Fund I, $325M final close
Lucid Diligence Brief: Ascenta Capital Fund I, $325M final close Professional…